TRPC3 and fatty liver disease: Liver-specific TRPC3 silencing aggravates alcohol-induced hepatic steatosis and liver injury by suppressing Ca2+/calmodulin-dependent protein kinase kinase 2 (CAMKK2)/AMPK signaling pathway.